frontotemporal-dementia

Documents about frontotemporal-dementia

• Frontotemporal dementia with right temporal predominance: a clinical comparison with left-predominant FTD.#440666NCBI PubMed Central
• Granulin loss and TMEM106B risk converge on lysosomal C-terminal fragment pathology in frontotemporal dementia#133204bioRxiv / medRxiv
• Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales#215713Ora Oxford University Research
• Comorbidity Between Anti-GAD65 Autoimmune Encephalitis and Behavioral Variant Frontotemporal Dementia: A Case Report.#235934NCBI PubMed Central
• Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family#992976ClinicalTrials.gov
• Computational Tools for Early Diagnosis of Memory Disorders#910270ClinicalTrials.gov
• Traumatic Brain Injury and Axonal Damage in the Pathogenesis of Frontotemporal Dementia: A Narrative Review.#123043NCBI PubMed Central
• Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.#218781NCBI PubMed Central
• Explainable EEG-based machine learning for early diagnosis of Alzheimer's disease and frontotemporal dementia.#326856NCBI PubMed Central
• Judgments about moral responsibility and determinism in patients with behavioural variant of frontotemporal dementia: Still compatibilists#712508PhilArchive
• Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized#859899ClinicalTrials.gov
• Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.#900866ClinicalTrials.gov
• Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders#829538ClinicalTrials.gov
• Pharmacological management in frontotemporal dementia and patient outcomes: a retrospective cohort study using the TriNetX platform.#1000970NCBI PubMed Central
• TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia#394557bioRxiv / medRxiv
• Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS#620182eScholarship
• Frontotemporal dementia characterization using neurite orientation dispersion and density imaging#185466IRIS
• Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicity.#232617NCBI PubMed Central
• Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD#234387ClinicalTrials.gov
• Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders#878015ClinicalTrials.gov
• Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling#123230Europe PMC
• Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET#838866ClinicalTrials.gov
• Supplementary Material for: Clinical presentation and diagnostic challenges of frontotemporal dementia in Brazil: A 15-year cohort study.#226649Figshare
• ADDIA Proof-of-Performance Clinical Study#834477ClinicalTrials.gov
• Care Ecosystem: Navigating Patients and Families Through Stages of Care#838017ClinicalTrials.gov
• NYSCF Scientific Discovery Biobank#871873ClinicalTrials.gov
• Granulin loss and TMEM106B risk converge on lysosomal C-terminal fragment pathology in frontotemporal dementia#135531Unpaywall
• Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS#867150ClinicalTrials.gov
• Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of <sup>1</sup> <sup>8</sup>F-SynVesT-1 and <sup>1</sup> <sup>8</sup>F-FDG PET#5448Europe PMC
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study#826957ClinicalTrials.gov
• More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease#830871ClinicalTrials.gov
• Cellular signatures underlying functional resilience in presymptomatic frontotemporal dementia#473066Open Access LMU
• Multi‑omics profiling reveals shared blood-brain barrier stress signatures and disease-specific vascular remodelingin capillary cerebral amyloid angiopathy and GRN-associated frontotemporal dementia#374173Europe PMC
• Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series#684108eScholarship
• Assessment of Social-emotional Functioning in Neurological Diseases#855618ClinicalTrials.gov
• Neural embedding of frailty in cognitively unimpaired aging and dementia across Latin America#159313HAL (France)
• Cognitive and Behavioural Profile of SOD1-ALS Across the ALS-FTD Spectrum: A Systematic Review#923139IRIS
• Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study#1001647Open Access LMU
• Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System#806326ClinicalTrials.gov
• Differential lysosomal burden in the excitatory and inhibitory neurons of the FTD-GRN brain.#156122HAL (France)
• Proteinopathies Expression in Skin of Neurodegenerative Disorders#835436ClinicalTrials.gov
• A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia#993830ClinicalTrials.gov
• Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers#784314eScholarship
• Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia#814674eScholarship
• Enhanced Positive Emotional Reactivity Undermines Empathy in Behavioral Variant Frontotemporal Dementia#491959eScholarship
• tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study#801224ClinicalTrials.gov
• Chapter 21 Neurodegenerative disorders of the human frontal lobes#683878eScholarship
• Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders#840159ClinicalTrials.gov